Tactile Systems Technology Inc
TCMD28.920USD
-0.420-1.43%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
645.95MMarket Cap
37.40P/E TTM
More Details of Tactile Systems Technology Inc Company
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Tactile Systems Technology Inc Info
Ticker SymbolTCMD
Company nameTactile Systems Technology Inc
IPO dateJul 28, 2016
CEODodd (Sheri L)
Number of employees1037
Security typeOrdinary Share
Fiscal year-endJul 28
Address3701 Wayzata Blvd, Suite 300
CityMINNEAPOLIS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55416
Phone18333822845
Websitehttps://www.tactilemedical.com/
Ticker SymbolTCMD
IPO dateJul 28, 2016
CEODodd (Sheri L)
Company Executives of Tactile Systems Technology Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
56.32K
+39.95%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
48.52K
+35.75%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
37.70K
+74.37%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
24.67K
-10.59%
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Ms. Laura G. King
Ms. Laura G. King
Director
Director
--
--
Dr. B. Vindell Washington, M.D.
Dr. B. Vindell Washington, M.D.
Independent Director
Independent Director
--
--
Mr. Sam Bentzinger
Mr. Sam Bentzinger
Investor Relations Contact Officer
Investor Relations Contact Officer
--
--
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
56.32K
+39.95%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
48.52K
+35.75%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
37.70K
+74.37%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
24.67K
-10.59%
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Ms. Laura G. King
Ms. Laura G. King
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2023
By BusinessUSD
Name
Revenue
Proportion
Lymphedema products
65.97M
83.61%
Airway clearance products
12.94M
16.39%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Lymphedema products
65.97M
83.61%
Airway clearance products
12.94M
16.39%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Morgan Stanley & Co. LLC
9.48%
Cadian Capital Management LP
9.20%
BlackRock Institutional Trust Company, N.A.
7.27%
The Vanguard Group, Inc.
6.93%
Paradigm Capital Management, Inc.
6.89%
Other
60.23%
Shareholders
Shareholders
Proportion
Morgan Stanley & Co. LLC
9.48%
Cadian Capital Management LP
9.20%
BlackRock Institutional Trust Company, N.A.
7.27%
The Vanguard Group, Inc.
6.93%
Paradigm Capital Management, Inc.
6.89%
Other
60.23%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.89%
Investment Advisor/Hedge Fund
35.00%
Hedge Fund
13.97%
Research Firm
10.79%
Individual Investor
2.72%
Sovereign Wealth Fund
0.65%
Pension Fund
0.43%
Bank and Trust
0.13%
Insurance Company
0.04%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
366
22.60M
101.18%
-8.77M
2025Q2
389
24.67M
110.65%
-7.05M
2025Q1
401
24.00M
103.20%
-7.47M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Morgan Stanley & Co. LLC
2.17M
9.72%
-8.32K
-0.38%
Jun 30, 2025
Cadian Capital Management LP
2.19M
9.84%
-116.79K
-5.06%
Aug 07, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
7.28%
-310.00K
-16.04%
Jun 30, 2025
The Vanguard Group, Inc.
1.51M
6.79%
+11.91K
+0.79%
Jun 30, 2025
Paradigm Capital Management, Inc.
1.62M
7.26%
+89.60K
+5.86%
Jun 30, 2025
Nomura Investment Management Business Trust
1.20M
5.4%
--
--
Mar 13, 2025
Dimensional Fund Advisors, L.P.
1.17M
5.24%
+139.18K
+13.54%
Jun 30, 2025
Capitolis Liquid Global Markets LLC
902.06K
4.05%
-155.64K
-14.71%
Jun 30, 2025
Acadian Asset Management LLC
683.66K
3.07%
+487.39K
+248.33%
Jun 30, 2025
Geode Capital Management, L.L.C.
575.64K
2.58%
-11.13K
-1.90%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Cambria Micro and SmallCap Shareholder Yield ETF
1.13%
Invesco NASDAQ Future Gen 200 ETF
0.61%
First Trust Active Factor Small Cap ETF
0.61%
Lattice Hartford Multifactor Small Cap ETF
0.58%
Federated Hermes MDT Small Cap Core ETF
0.38%
Unusual Whales Subversive Democratic Trading ETF
0.37%
iShares US Small Cap Value Factor ETF
0.33%
Royce Quant Small-Cap Quality Value ETF
0.21%
Vanguard US Multifactor ETF
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
View more
Cambria Micro and SmallCap Shareholder Yield ETF
Proportion1.13%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.61%
First Trust Active Factor Small Cap ETF
Proportion0.61%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.58%
Federated Hermes MDT Small Cap Core ETF
Proportion0.38%
Unusual Whales Subversive Democratic Trading ETF
Proportion0.37%
iShares US Small Cap Value Factor ETF
Proportion0.33%
Royce Quant Small-Cap Quality Value ETF
Proportion0.21%
Vanguard US Multifactor ETF
Proportion0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.12%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Tactile Systems Technology Inc?
The top five shareholders of Tactile Systems Technology Inc are:
Morgan Stanley & Co. LLC holds 2.17M shares, accounting for 9.72% of the total shares.
Cadian Capital Management LP holds 2.19M shares, accounting for 9.84% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.62M shares, accounting for 7.28% of the total shares.
The Vanguard Group, Inc. holds 1.51M shares, accounting for 6.79% of the total shares.
Paradigm Capital Management, Inc. holds 1.62M shares, accounting for 7.26% of the total shares.
Morgan Stanley & Co. LLC holds 2.17M shares, accounting for 9.72% of the total shares.
Cadian Capital Management LP holds 2.19M shares, accounting for 9.84% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.62M shares, accounting for 7.28% of the total shares.
The Vanguard Group, Inc. holds 1.51M shares, accounting for 6.79% of the total shares.
Paradigm Capital Management, Inc. holds 1.62M shares, accounting for 7.26% of the total shares.
What are the top three shareholder types of Tactile Systems Technology Inc?
The top three shareholder types of Tactile Systems Technology Inc are:
Morgan Stanley & Co. LLC
Cadian Capital Management LP
BlackRock Institutional Trust Company, N.A.
Morgan Stanley & Co. LLC
Cadian Capital Management LP
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Tactile Systems Technology Inc (TCMD)?
As of 2025Q3, 366 institutions hold shares of Tactile Systems Technology Inc, with a combined market value of approximately 22.60M, accounting for 101.18% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -9.47%.
What is the biggest source of revenue for Tactile Systems Technology Inc?
In FY2025Q2, the Lymphedema products business generated the highest revenue for Tactile Systems Technology Inc, amounting to 65.97M and accounting for 83.61% of total revenue.
